What Analysts Were Expecting After Second Sight Medical Products Inc. (NASDAQ: EYES) rose 12.21% – Stocks Register
Home  »  Finance   »  What Analysts Were Expecting After Second Sight Me...

What Analysts Were Expecting After Second Sight Medical Products Inc. (NASDAQ: EYES) rose 12.21%

Second Sight Medical Products Inc. (NASDAQ:EYES) shares, rose in value on Wednesday, 07/21/21, with the stock price up by 12.21% to the previous day’s close as strong demand from buyers drove the stock to $4.32.

Actively observing the price movement in the last trading, the stock closed the session at $3.85, falling within a range of $3.86 and $4.40. The value of beta (5-year monthly) was 3.43. Referring to stock’s 52-week performance, its high was $20.00, and the low was $0.69. On the whole, EYES has fluctuated by -32.92% over the past month.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


With the market capitalization of Second Sight Medical Products Inc. currently standing at about $164.68 million, investors are eagerly awaiting this quarter’s results, scheduled for Jun 26, 2020.

Analysts have estimated the company’s revenue for the quarter at $240k, with a low estimate of $240k and a high estimate of $240k. According to the average forecast, sales growth in current quarter could jump down -49.20%, compared to the corresponding quarter of last year.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that EYES’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 25% Sell while long term indicators on average have been pointing out that it is a Hold.

1 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. The stock is rated as a Hold by 0 analyst(s), 1 recommend it as a Buy and 0 called the EYES stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Buy.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of EYES currently trading nearly -4.47% and -18.51% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.53, while the 7-day volatility ratio is showing 8.65% which for the 30-day chart, stands at 7.44%. Furthermore, Second Sight Medical Products Inc. (EYES)’s beta value is 3.39, and its average true range (ATR) is 0.42. The company’s stock has been forecasted to trade at an average price of $10.00 over the course of the next 52 weeks, with a low of $10.00 and a high of $10.00. Based on these price targets, the low is -131.48% off current price, whereas the price has to move -131.48% to reach the yearly target high. Additionally, analysts’ median price of $10.00 is likely to be welcomed by investors because it represents a decrease of -131.48% from the current levels.

A comparison of Second Sight Medical Products Inc. (EYES) with its peers suggests the former has fared considerably weaker in the market. EYES showed an intraday change of 12.21% in last session, and over the past year, it grew by 348.78%%. In comparison, Invacare Corporation (IVC) has moved higher at 1.64% on the day and was up 7.97% over the past 12 months. On the other hand, the price of Cutera Inc. (CUTR) has risen 3.60% on the day. The stock, however, is off 265.95% from where it was a year ago. Other than that, the overall performance of the S&P 500 during the last trading session shows that it gained 0.82%. Meanwhile, the Dow Jones Industrial Improved by 0.83%.

Data on historical trading for Second Sight Medical Products Inc. (NASDAQ:EYES) indicates that the trading volumes over the past 10 days have averaged 1.66 million and over the past 3 months, they’ve averaged 5.40 million. According to company’s latest data on outstanding shares, there are 23.54 million shares outstanding.

>> 7 Top Picks for the Post-Pandemic Economy <<

Nearly 35.63% of Second Sight Medical Products Inc.’s shares belong to company insiders and institutional investors own 17.60% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.75 million shares as on May 27, 2021, resulting in a short ratio of 0.21. According to the data, the short interest in Second Sight Medical Products Inc. (EYES) stood at 6.27% of shares outstanding as of May 27, 2021; the number of short shares registered in Apr 29, 2021 reached 3.85 million. The stock has risen by 131.02% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EYES stock heading into the next quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam